A Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy Volunteers

Clinical trial NCT02053454 · COMPLETED

Trial details

NCT number: NCT02053454
Sponsor: Alnylam Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Transthyretin (TTR)-Mediated Amyloidosis

Start date: 2014-01-01
Primary completion: 2014-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.